224 digital health funding deals in 2017

Funding

This was an impressive year for digital health investment. In total, MobiHealthNews covered 224 companies’ funding announcements constituting just over $5 billion in investments — roughly twice the amount we saw last year. Fifty-two of these funding announcements were in the first quarter of the year ($1.32 billion), 81 in the second ($2.58 billion), 53 in the third ($579 million), and 38 in the fourth ($553 million).

Top digital health funding deals of 2017 ($100 million or more)

Verily, the Alphabet subsidiary formerly known as Google Life Sciences, raised $800 million in funding from Temasek, a Singapore-based investment company. More
Outcome Health, a maker of waiting room screens and tablets for patient education and pharmaceutical marketing, raised at least $500 million in first round funding, lending the company a valuation of around $5 billion (although the use of these funds has come into question amidst recent events). More
Peloton, the New York City-based technology company that has seen impressive success combining exercise bikes with tablets to create virtual cycling classes, raised $325 million in late stage funding. More
Modernizing Medicine, which makes a mobile-based EHR for specialists, raised $231 million from global private equity firm Warburg Pincus. More
Bright Health, the Minnesota-based health insurance startup that boasts “a smarter, more connected” experience, raised a new round of $160 million. More
PatientPoint, the Cincinnati, Ohio-based company that makes education and engagement platforms for patients and providers, raised $140 million in new funding from Searchlight Capital Partners and Silver Point Capital. More
Clover Health, an insurance startup with a patient engagement bent, raised $130 million in a round led by existing investor Greenoaks Capital Management. More
PatientsLikeMe, which serves as an information, support, and study recruitment source for people living with chronic conditions, secured $100 million in new funding. More